These pathological modifications result in tau aggregation in the neuronal somata leading to the development of neurodegenerative disorders collectively called tauopathies such as Alzheimer’s disease, corticobasal degeneration, progressive supranuclear palsy, frontotemporal dementia, and others [5,6,9]. This evidence concerns the gene MAPT and Alzheimer disease.